公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy | Wu S.-H.; Hsieh C.-C.; SZU-CHUN HSU ; MING YAO ; Hsiao J.-K.; Wang S.-W.; CHIH-PENG LIN ; Huang D.-M. | Journal of Advanced Research | 18 | 17 | |
2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
2003 | Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | SHANG-YI HUANG ; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO ; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; HWEI-FANG TIEN ; MING-CHING SHEN ; YAO-CHANG CHEN | Annals of Hematology | 12 | 10 | |
2012 | Relapse of acute myeloid leukemia at the pituitary gland: A case report and review of literature | Lin H.-W.; SHYANG-RONG SHIH ; MING YAO ; TIEN-SHANG HUANG | Endocrine Pathology | 8 | 6 | |
2018 | Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial | Lin C.-T.; PO-REN HSUEH ; SHANG-JU WU ; MING YAO ; BOR-SHENG KO ; Li C.-C.; Hsu C.-A.; JIH-LUH TANG ; HWEI-FANG TIEN | Biology of Blood and Marrow Transplantation | 4 | 3 | |
2011 | Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation | Chou Y.-C.; Lin S.-J.; Lu J.; TE-HUEI YEH ; Chen C.-L.; Weng P.-L.; Lin J.-H.; MING YAO ; CHING-HWA TSAI | Blood | 21 | 20 | |
2018 | Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma | Chieh-Lung Cheng ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN | European journal of haematology | 7 | 8 | |
2015 | Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults | Chieh-Lung Cheng ; Li, Chi-Cheng; HSIN-AN HOU ; Fang, Wei-Quan; Chang, Chin-Hao; Lin, Chien-Ting; JIH-LUH TANG ; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | BMC cancer | 42 | 40 | |
2007 | RUNX1 gene mutation in primary myelodysplastic syndrome - The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome | Chen, Chien-Yuan ; LIANG-IN LIN ; JIH-LUH TANG ; BOR-SHENG KO ; WOEI TSAY ; WEN-CHIEN CHOU ; MING YAO ; SHANG-JU WU ; Tseng M.-H.; HWEI-FANG TIEN | British Journal of Haematology | 115 | 106 | |
2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
2012 | Simultaneous determination of triazole antifungal drugs in human plasma by sweeping-micellar electrokinetic chromatography | Lin, Shu-Chiao; Liu, Hsiang-Yin; SHU-WEN LIN ; MING YAO ; UN-IN WU ; HSIU-PO KUO ; CHING-HUA KUO | Analytical and Bioanalytical Chemistry | 19 | | |
2003 | SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia | Chen, Chien-Yuan ; WOEI TSAY ; JIH-LUH TANG ; Shen, Hwei-Ling; SHU-WHA LIN ; Huang, Sheng-Yi; MING YAO ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang, Chiu-Hwa; HWEI-FANG TIEN | Genes, chromosomes & cancer | 108 | 89 | |
2016 | Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma | SHANG-YI HUANG ; Lin, Hsiu-Hsia; CHUNG-WU LIN ; Li, Chi-Cheng; MING YAO ; JIH-LUH TANG ; HSIN-AN HOU ; WOEI TSAY ; Chou, Sheng-Je; Chieh-Lung Cheng ; HWEI-FANG TIEN | Oncotarget | 26 | 26 | |
2011 | Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever | Lin C.-H.; MING YAO ; SZU-CHUN HSU ; CHAO-CHI HO ; Lin M.-T.; Lin C.-A.; Hu F.-C.; CHONG-JEN YU ; HWEI-FANG TIEN | Critical Care Medicine | 7 | 9 | |
2016 | Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia | HSIN-AN HOU ; Liu, Chieh-Yu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; LIANG-IN LIN ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; JIH-LUH TANG ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, Chien-Ting; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Oncotarget | 67 | 62 | |
2022 | Stem cell transplant for mantle cell lymphoma in Taiwan | Wang Y.-H.; Hsieh C.-Y.; Hsiao L.-T.; Lin T.-L.; Liu Y.-C.; MING YAO ; Tan T.-D.; BOR-SHENG KO | Scientific Reports | 1 | 0 | |
2005 | Successful treatment of acute hepatitis A-associated hemophagocytic syndrome by intravenous immunoglobulin | Tai C.-M.; CHUN-JEN LIU ; MING YAO | Journal of the Formosan Medical Association | 11 | 14 | |
2024 | Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan | Huang, Yi-Che; Hsiao, Fei-Yuan; Guan, Shang-Ting; MING YAO ; Liu, Chia-Jen; Chen, Tzu-Ting; Lin, Tung-Liang; Liu, Yi-Chang; Chen, Tsai-Yun; Hong, Ying-Chung; Ma, Ming-Chun; Tan, Tran-Der; Wang, Chuan-Cheng; Wu, Yi-Ying; Liao, Po-Wei; Wu, Yi-Feng; Chen, Yi-Yang; Yu, Yuan-Bin; Hsieh, Yao-Yu; Lee, Ming-Yang; Liu, Jia-Hau; Lin, Shu-Wen; BOR-SHENG KO | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | | | |
2011 | TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; HSIN-AN HOU ; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 255 | 235 | |
2015 | TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution | HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo, Y.-Y.; Liu, C.-Y.; LIANG-IN LIN ; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; JIH-LUH TANG ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood Cancer Journal | 112 | 111 | |